	Ebit		Date
AbbVie	USD 5.81B	4.36B	2025-12
Agios Pharmaceuticals	USD -116.87M	10.19M	2025-09
Alnylam Pharmaceuticals	USD -29.96M	34.85M	2025-09
Amgen	USD 3.96B	464M	2025-12
Arrowhead Research	USD 40.81M	17.01M	2025-12
Astellas Pharma	JPY 134.54B	30.13B	2025-12
AstraZeneca	USD -1.5B	5.01B	2025-09
Bayer	EUR -399M	363M	2025-09
Biogen	USD 659.6M	157M	2025-09
BioMarin Pharmaceutical	USD -31.69M	308.58M	2025-09
Bristol-Myers Squibb	USD 3.47B	567M	2025-12
Daiichi Sankyo	JPY 89.54B	42.01B	2025-12
Eli Lilly	USD 8.99B	1.57B	2025-12
Exelixis	USD 256.36M	42.78M	2025-09
Gilead Sciences	USD 3.51B	810M	2025-09
GlaxoSmithKline	GBP 1.44B	1.35B	2025-12
Incyte	USD 431.31M	120.49M	2025-09
Ionis Pharmaceuticals	USD -160.18M	304.96M	2025-09
Merck	USD 6.24B	1.32B	2025-12
Moderna	USD -260M	557M	2025-09
Novartis	USD -9.19B	13.87B	2025-06
Novartis	USD 4.48B	343M	2025-09
Pfizer	USD 4.65B	71M	2025-12
Regeneron Pharmaceuticals	USD 898.6M	211.3M	2025-12
Roche Holding	CHF 9.56B	2.1B	2025-12
Sarepta Therapeutics	USD -62.88M	178.46M	2025-09
Vertex Pharmaceuticals	USD 1.24B	84.6M	2025-09

Agios Pharmaceuticals - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Feb 2026.